A detailed history of Financial & Tax Architects, LLC transactions in Sanofi stock. As of the latest transaction made, Financial & Tax Architects, LLC holds 10,299 shares of SNY stock, worth $494,043. This represents 0.15% of its overall portfolio holdings.

Number of Shares
10,299
Previous 9,715 6.01%
Holding current value
$494,043
Previous $471 Million 25.92%
% of portfolio
0.15%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$48.54 - $58.53 $28,347 - $34,181
584 Added 6.01%
10,299 $594 Million
Q2 2024

Aug 09, 2024

BUY
$45.39 - $50.36 $110,978 - $123,130
2,445 Added 33.63%
9,715 $471 Million
Q1 2024

May 08, 2024

BUY
$45.75 - $52.48 $87,062 - $99,869
1,903 Added 35.46%
7,270 $353 Million
Q4 2023

Jan 25, 2024

SELL
$43.13 - $54.79 $8,022 - $10,190
-186 Reduced 3.35%
5,367 $267 Million
Q3 2023

Oct 19, 2023

SELL
$50.95 - $55.2 $3,515 - $3,808
-69 Reduced 1.23%
5,553 $298 Million
Q2 2023

Jul 25, 2023

SELL
$50.45 - $57.18 $35,516 - $40,254
-704 Reduced 11.13%
5,622 $303 Million
Q1 2023

Apr 26, 2023

SELL
$45.86 - $54.45 $825 - $980
-18 Reduced 0.28%
6,326 $344 Million
Q4 2022

Feb 09, 2023

BUY
$38.86 - $48.55 $246,527 - $308,001
6,344 New
6,344 $311 Million
Q2 2022

Aug 25, 2023

SELL
$48.99 - $57.46 $40,220 - $47,174
-821 Reduced 11.03%
6,621 $331 Million
Q1 2022

Aug 25, 2023

BUY
$48.48 - $53.65 $88,233 - $97,643
1,820 Added 32.37%
7,442 $382 Million
Q4 2021

Aug 25, 2023

SELL
$47.07 - $52.35 $2,824 - $3,141
-60 Reduced 0.79%
7,545 $378 Million
Q3 2021

Aug 25, 2023

BUY
$47.89 - $53.12 $1,676 - $1,859
35 Added 0.46%
7,605 $367 Million
Q2 2021

Aug 25, 2023

SELL
$49.36 - $54.25 $7,502 - $8,246
-152 Reduced 1.97%
7,570 $399 Million
Q1 2021

Aug 25, 2023

BUY
$45.46 - $50.51 $95,466 - $106,071
2,100 Added 37.35%
7,722 $382 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Financial & Tax Architects, LLC Portfolio

Follow Financial & Tax Architects, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial & Tax Architects, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial & Tax Architects, LLC with notifications on news.